Search results for: 'Overview of European In vitro Diagnostics Market'

This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

In this research piece, we look at the potential of the metaverse globally and, in particular, the impact on European businesses. The report uses Frost & Sullivan’s working definition for the metaverse and considers what the metaverse is, what it is not, and what it can create. The metaverse will be the next iteration of the internet (Web 3.0), and...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...

14 Mar 2022  |  North America  |  Market Outlook

Next-generation Diagnostics Outlook, 2022

Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

Infographics

×

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

In the last decade, digital transformation initiatives have rapidly developed in the global defense market. The Western Armed forces had to accelerate digital footprint implementation and adopt the cloud IT infrastructure to handle, analyze, and store mass data on its various operational utilities. These initiatives are inevitable, particularly for...

10 May 2018  |  North America  |  Market Research

Global Tissue Diagnostics Market, Forecast to 2022

Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market

Infographics

×

Key Issues Addressed

Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...